Detalhe da pesquisa
1.
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.
Nat Biotechnol
; 41(3): 399-408, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593394
2.
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes.
Trials
; 23(1): 414, 2022 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585600
3.
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes.
BMJ Open
; 11(12): e053669, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876434
4.
JIB.tools 2.0 - A Bioinformatics Registry for Journal Published Tools with Interoperability to bio.tools.
J Integr Bioinform
; 16(4)2020 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31913853
5.
DBDS Genomic Cohort, a prospective and comprehensive resource for integrative and temporal analysis of genetic, environmental and lifestyle factors affecting health of blood donors.
BMJ Open
; 9(6): e028401, 2019 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182452
6.
Author Correction: Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.
Nat Biotechnol
; 41(7): 1026, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130959